Author Question: The nurse is planning care for a newly admitted client diagnosed with pulmonary embolism. The nurse ... (Read 90 times)

cnetterville

  • Hero Member
  • *****
  • Posts: 547
The nurse is planning care for a newly admitted client diagnosed with pulmonary embolism. The nurse anticipates the client will need anticoagulant therapy. What is true regarding this therapy for the treatment of this condition?
 
  A) It is considered second-line treatment.
  B) Major hemorrhage is common.
  C) Heparin and warfarin (Coumadin) are usually initiated at the same time.
  D) Heparin alters the synthesis of vitamin K-dependent clotting factors, preventing further clots.

Question 2

The nruse is providing care to several clients on a medical-surgical unit. Which client is at highest risk for a nonthrombotic pulmonary embolism?
 
  A) The client who is receiving intravenous pain medication.
  B) The client who is postoperative from a femur fracture repair.
  C) The client with a primary lung tumor.
  D) The client who uses intravenous illicit drugs.



ilianabrrr

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

Answer: C

Heparin and warfarin are usually initiated at the same time for the treatment of pulmonary embolus. Anticoagulant therapy is the standard first-line treatment of pulmonary embolism. While major hemorrhage is uncommon, bleeding may occur. Warfarin, not heparin, alters the synthesis of vitamin K-dependent clotting factors.

Answer to Question 2

Answer: B

Fat emboli are the most common nonthrombotic pulmonary emboli. A fat embolism usually occurs after fracture of long bone (typically the femur) releases bone marrow fat into the circulation. The other clients may be at risk for pulmonary embolism; however, they are incorrect choices for the most common cause of nonthrombotic pulmonary emboli.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

For a complete list of videos, visit our video library